Study of the effects of paf-acether on human nasal airways

E. Leggieri, A. Tedeschi, M. Lorini, A. Bianco, A. Miadonna

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

In 6 normal subjects and 6 patients with allergic rhinitis, nasal response to insufflation of paf-acether (paf, platelet-activating factor), lyso-paf and histamine was evaluated. Nasal challenge with paf, at doses of 300 and 600 nM, induced nasal obstruction, associated with an increase in nasal airway resistance, measured by anterior passive rhinomanometry. Maximum increase in nasal airway resistance was observed at 30 min after challenge (mean percent change +481 with 600 nM paf; P <0.05). Other symptoms induced by paf insufflation were rhinorrhea (6 out of 12 subjects), itching (8 out of 12), sneezing (4 out of 12) and a burning sensation (6 out of 12). No differences were observed between normal and rhinitic subjects, concerning nasal sensitivity to paf. Neither nasal symptoms nor changes in nasal airway resistance were observed after nasal challenge with lyso-paf (300 and 600 nM); by contrast, histamine (100 nM) induced sneezing, nasal obstruction, itching and rhinorrhea in all the studied subjects, associated with an increase in nasal airway resistance (maximum 5 min after challenge; percent change +358; P <0.02). Nasal effects of paf were not mediated by histamine, since no increase in histamine levels was observed in nasal washings following paf insufflation. We conclude that paf may have pathogenetic relevance in allergic rhinitis.

Original languageEnglish
Pages (from-to)466-471
Number of pages6
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume46
Issue number6
Publication statusPublished - 1991

Fingerprint

Platelet Activating Factor
Nose
Airway Resistance
Insufflation
Histamine
Sneezing
Nasal Obstruction
Pruritus
Nasal Lavage Fluid
Rhinomanometry

Keywords

  • Allergic rhinitis
  • Nasal airway resistance
  • Nasal mucosa
  • Paf-acether

ASJC Scopus subject areas

  • Immunology

Cite this

Leggieri, E., Tedeschi, A., Lorini, M., Bianco, A., & Miadonna, A. (1991). Study of the effects of paf-acether on human nasal airways. Allergy: European Journal of Allergy and Clinical Immunology, 46(6), 466-471.

Study of the effects of paf-acether on human nasal airways. / Leggieri, E.; Tedeschi, A.; Lorini, M.; Bianco, A.; Miadonna, A.

In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 46, No. 6, 1991, p. 466-471.

Research output: Contribution to journalArticle

Leggieri, E, Tedeschi, A, Lorini, M, Bianco, A & Miadonna, A 1991, 'Study of the effects of paf-acether on human nasal airways', Allergy: European Journal of Allergy and Clinical Immunology, vol. 46, no. 6, pp. 466-471.
Leggieri E, Tedeschi A, Lorini M, Bianco A, Miadonna A. Study of the effects of paf-acether on human nasal airways. Allergy: European Journal of Allergy and Clinical Immunology. 1991;46(6):466-471.
Leggieri, E. ; Tedeschi, A. ; Lorini, M. ; Bianco, A. ; Miadonna, A. / Study of the effects of paf-acether on human nasal airways. In: Allergy: European Journal of Allergy and Clinical Immunology. 1991 ; Vol. 46, No. 6. pp. 466-471.
@article{a32365c0d0504d1ca3beb9546aec443e,
title = "Study of the effects of paf-acether on human nasal airways",
abstract = "In 6 normal subjects and 6 patients with allergic rhinitis, nasal response to insufflation of paf-acether (paf, platelet-activating factor), lyso-paf and histamine was evaluated. Nasal challenge with paf, at doses of 300 and 600 nM, induced nasal obstruction, associated with an increase in nasal airway resistance, measured by anterior passive rhinomanometry. Maximum increase in nasal airway resistance was observed at 30 min after challenge (mean percent change +481 with 600 nM paf; P <0.05). Other symptoms induced by paf insufflation were rhinorrhea (6 out of 12 subjects), itching (8 out of 12), sneezing (4 out of 12) and a burning sensation (6 out of 12). No differences were observed between normal and rhinitic subjects, concerning nasal sensitivity to paf. Neither nasal symptoms nor changes in nasal airway resistance were observed after nasal challenge with lyso-paf (300 and 600 nM); by contrast, histamine (100 nM) induced sneezing, nasal obstruction, itching and rhinorrhea in all the studied subjects, associated with an increase in nasal airway resistance (maximum 5 min after challenge; percent change +358; P <0.02). Nasal effects of paf were not mediated by histamine, since no increase in histamine levels was observed in nasal washings following paf insufflation. We conclude that paf may have pathogenetic relevance in allergic rhinitis.",
keywords = "Allergic rhinitis, Nasal airway resistance, Nasal mucosa, Paf-acether",
author = "E. Leggieri and A. Tedeschi and M. Lorini and A. Bianco and A. Miadonna",
year = "1991",
language = "English",
volume = "46",
pages = "466--471",
journal = "Allergy: European Journal of Allergy and Clinical Immunology",
issn = "0105-4538",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Study of the effects of paf-acether on human nasal airways

AU - Leggieri, E.

AU - Tedeschi, A.

AU - Lorini, M.

AU - Bianco, A.

AU - Miadonna, A.

PY - 1991

Y1 - 1991

N2 - In 6 normal subjects and 6 patients with allergic rhinitis, nasal response to insufflation of paf-acether (paf, platelet-activating factor), lyso-paf and histamine was evaluated. Nasal challenge with paf, at doses of 300 and 600 nM, induced nasal obstruction, associated with an increase in nasal airway resistance, measured by anterior passive rhinomanometry. Maximum increase in nasal airway resistance was observed at 30 min after challenge (mean percent change +481 with 600 nM paf; P <0.05). Other symptoms induced by paf insufflation were rhinorrhea (6 out of 12 subjects), itching (8 out of 12), sneezing (4 out of 12) and a burning sensation (6 out of 12). No differences were observed between normal and rhinitic subjects, concerning nasal sensitivity to paf. Neither nasal symptoms nor changes in nasal airway resistance were observed after nasal challenge with lyso-paf (300 and 600 nM); by contrast, histamine (100 nM) induced sneezing, nasal obstruction, itching and rhinorrhea in all the studied subjects, associated with an increase in nasal airway resistance (maximum 5 min after challenge; percent change +358; P <0.02). Nasal effects of paf were not mediated by histamine, since no increase in histamine levels was observed in nasal washings following paf insufflation. We conclude that paf may have pathogenetic relevance in allergic rhinitis.

AB - In 6 normal subjects and 6 patients with allergic rhinitis, nasal response to insufflation of paf-acether (paf, platelet-activating factor), lyso-paf and histamine was evaluated. Nasal challenge with paf, at doses of 300 and 600 nM, induced nasal obstruction, associated with an increase in nasal airway resistance, measured by anterior passive rhinomanometry. Maximum increase in nasal airway resistance was observed at 30 min after challenge (mean percent change +481 with 600 nM paf; P <0.05). Other symptoms induced by paf insufflation were rhinorrhea (6 out of 12 subjects), itching (8 out of 12), sneezing (4 out of 12) and a burning sensation (6 out of 12). No differences were observed between normal and rhinitic subjects, concerning nasal sensitivity to paf. Neither nasal symptoms nor changes in nasal airway resistance were observed after nasal challenge with lyso-paf (300 and 600 nM); by contrast, histamine (100 nM) induced sneezing, nasal obstruction, itching and rhinorrhea in all the studied subjects, associated with an increase in nasal airway resistance (maximum 5 min after challenge; percent change +358; P <0.02). Nasal effects of paf were not mediated by histamine, since no increase in histamine levels was observed in nasal washings following paf insufflation. We conclude that paf may have pathogenetic relevance in allergic rhinitis.

KW - Allergic rhinitis

KW - Nasal airway resistance

KW - Nasal mucosa

KW - Paf-acether

UR - http://www.scopus.com/inward/record.url?scp=0025831794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025831794&partnerID=8YFLogxK

M3 - Article

VL - 46

SP - 466

EP - 471

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

SN - 0105-4538

IS - 6

ER -